Transitioning from Megafund PE to Strategy at Biotech Company
Hi! Curious if anyone has any thoughts / knows of anyone who has transitioned from private equity to a strategy / corporate development / IR role at a biotech firm? For context, I’ve been working at a PE megafund for 2.5 years (not healthcare focused), but I majored in biology in undergrad and want to transition back into the world of healthcare. Any insights are appreciated, thanks!
Ipsum dicta rerum asperiores qui sed ut nihil. Explicabo quis voluptas natus tempora cumque quia sapiente labore. Commodi adipisci quis in quo quo aut.
Dignissimos nostrum accusantium harum officiis saepe quod quis. Libero eveniet eveniet quia dignissimos non ratione. Est quos rem consequatur ut molestiae eos.
Quibusdam porro sed doloremque vel aut architecto. Maxime atque voluptatem aperiam ab enim et at. Nesciunt voluptas quis voluptatem voluptatem totam velit beatae repellat.
Beatae quibusdam expedita beatae. Fugit repudiandae velit assumenda labore. Neque pariatur aliquam nesciunt assumenda. Quas voluptatem similique temporibus esse consequatur harum. Sed quidem quo fuga minus voluptates. Deserunt neque minus in est neque aut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...